Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Huasong Xia"'
Publikováno v:
Journal of Interventional Cardiology, Vol 2022 (2022)
Background. Apelin-12 and estimated glomerular filtration rate (eGFR) are considered prognostic factors for ST-segment elevation myocardial infarction (STEMI). However, little is known about whether the combined use of these two biomarkers could enha
Externí odkaz:
https://doaj.org/article/1e8cff393df7440eb1130433e0de9836
Publikováno v:
Electronics; Volume 12; Issue 11; Pages: 2514
With the growth of university chemistry experiment projects, the corresponding laboratory safety risks are increasing year by year for scientific research personnel, and specialized equipment. However, accident data are not stored systematically for
Autor:
Yi Chen, Hongzhou Zhang, Yuxin Chen, Meng Li, Wei Luo, Yue Liu, Yang Fu, Huasong Xia, Cong Xu, Yu Jiang, Yanqing Wu
Publikováno v:
Clinical Rheumatology. 41:1873-1887
Colchicine is an ancient anti-inflammatory drug. In recent years, an increasing number of studies have shown that colchicine improves the prognosis of patients with coronary artery disease (CAD), while other studies have reported the opposite. The ai
Publikováno v:
Journal of healthcare engineering. 2022
Introduction. Liver carcinoma is one of the most common cancers in the world and remains one of the most difficult cancers to treat. Hepatocellular cancer is the most important type of liver cancer (90%). RING Finger 44 (RNF44) is one of the E3 ligas
Identification of Hypoxia-related Genes in Acute Myocardial Infarction Using Bioinformatics Analysis
Publikováno v:
Combinatorial chemistryhigh throughput screening.
Background: Acute myocardial infarction (AMI) remains one of the most fatal diseases worldwide. Persistent ischemia and hypoxia are implicated as a significant mechanism in the development of AMI. However, no hypoxia-related gene targets of AMI have
Publikováno v:
Clinical and experimental hypertension (New York, N.Y. : 1993). 43(8)
Objectives: This study was to investigate whether long-term amlodipine-based combination therapy attenuates seasonal variation of office blood pressure (BP) in hypertensive patients. Methods: The d...
BACKGROUND: It is reported that dipeptidyl peptidase-4 (DPP-4) inhibitors can exert a protective effect on the cardiovascular system other than the glucose-lowering effect. However, whether DPP-4 inhibitors can delay or prevent the progression of car
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0b40c83ee2a5765058728fa141d53f9b
https://doi.org/10.21203/rs.3.rs-120663/v1
https://doi.org/10.21203/rs.3.rs-120663/v1
Autor:
Meng Li, Ping Li, Yang Hu, Yanqing Wu, Yang Fu, Fulin Song, Xiaoshu Cheng, Xiaopei Sun, Yue Liu, Huan Hu, Huasong Xia
Previous studies have demonstrated that targeting inflammation is a promising strategy for treating lipopolysaccharide (LPS)-induced sepsis and related heart injury. Interleukin-35 (IL-35), which consists of two subunits, Epstein–Barr virus-induced
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6a4e387c8d0f8b95820349114ae8a1dc
Publikováno v:
Experimental Cell Research. 407:112784
Inflammation is an essential factor contributing to sepsis-induced endothelial cell (EC) activation. Interleukin-35 (IL-35) is an anti-inflammatory/immunosuppressive cytokine that exerts protective effects on many inflammatory diseases. In this study
Publikováno v:
International Immunopharmacology. 95:107528
Interleukin (IL)-38 is the tenth member of the IL-1 cytokine family. IL-38 shares high similarity with IL-36Ra and IL-1Ra and can bind to their receptors, thus exerting an anti-inflammatory effect. Despite the lack of a signal peptide, IL-38 can be r